Re-envisioning clinical trial design in systemic sclerosis

By sjmartinez • May 10, 2025

Volkmann ER, Tashkin DP, Smith V. Re-envisioning clinical trial design in systemic sclerosis. Expert Rev Clin Immunol. 2025 May 8. doi: 10.1080/1744666X.2025.2500612. Epub ahead of print. PMID: 40339169.

Tags: clinical trials, controlled clinical trials, discovery, Publications, Pulmonary, Critical Care & Sleep Medicine, randomized, Rheumatology, Scleroderma, systemic sclerosis

Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors

Doni Jayavelu N, Samaha H, Wimalasena ST, Hoch A, Gygi JP, Gabernet G, Ozonoff A, Liu S, Milliren CE, Levy O, Baden LR, Melamed E,[...]

Pancreatic cancer: molecular pathogenesis and emerging therapeutic strategies

Rozengurt E, Eibl G. Pancreatic cancer: molecular pathogenesis and emerging therapeutic strategies. Signal Transduct Target Ther. 2026 Jan 3;11(1):6. doi: 10.1038/s41392-025-02499-y. PMID: 41484057; PMCID: PMC12764932.

Increased Autoimmunity Burden Is a Risk Factor for Developing Irritable Bowel Syndrome-Like Symptoms in Quiescent Inflammatory Bowel Disease

Chang A, Shahrvini B, Oh J, Prajapati DP, Baniqued M, Harmon R, Greb AC, Bonthala N, Sauk JS, Shin A, Chang L, Limketkai BN. Increased[...]